BioVie Inc (NASDAQ:BIVI) has announced that it will be added as a member of the US small-cap Russell 2000 and Russell 3000 Indexes, effective after the US market opens on June 26, as part of the 2023 Russell indexes reconstitution.
The company noted that membership in the Russell 2000 Index, which remains in place for one year, is based on membership in the broad-market Russell 3000 Index. The stock also was automatically included in the appropriate growth and value indexes, it added.
Gander Gold Corp (CSE:GAND) said it has identified 14 high-priority target areas across its Gander North Project, a 485-square-kilometer area in Newfoundland, with some stretching up to 8 or 9 kilometers in length.
This development comes as Gander Gold aims to make a potential new gold discovery in an area where no previous drilling or systematic exploration has taken place.
With the drill rig mobilised, Solis Minerals Ltd (ASX:SLM, TSX-V:SLMN, OTCQB:SLMFF) has begun its maiden drill program at its flagship Jaguar Lithium Project in Brazil as it looks to build a new battery minerals business in South America.
The news comes just 22 days after an option agreement was executed to acquire the project and only 15 days after the company received firm commitments to raise A$8.155 million to fully fund the start of exploration drilling at the Jaguar and Borborema lithium projects.
PyroGenesis Canada Inc has announced the voting results from its annual meeting of shareholders held on June 22, 2023 in a virtual format. A total of approximately 47.4% of the issued and outstanding common shares of PyroGenesis were represented at the meeting. All of the nominees for election as directors of PyroGenesis referred to in its management information circular for the meeting were elected. Shareholders also approved the appointment of Raymond Chabot Grant Thornton LLP as auditor of PyroGenesis.
Medivolve Inc has reported that the nominees listed in the management information circular dated May 19, 2023, for the 2023 annual and special meeting of shareholders were elected as directors of the company. Shareholders at the meeting also approved the appointment of the company’s auditors, McGovern Hurley LLP, the company’s omnibus incentive plan, and the name change to Medidoc Inc. The company said 15.76% of all of the issued and outstanding shares of the company were represented at the meeting.
Globex Mining Enterprises Inc has announced that all five nominees listed in its 2023 management information circular were re-elected as directors at Globex’s annual meeting of shareholders held in Toronto, Ontario, on Thursday June 22, 2023.
Erdene Resource Development Corporation has announced the appointment of two executives to its primary Mongolian subsidiary, Erdene Mongol LLC, with Bilguun Ankhbayar appointed as chief executive officer and Jon M. L. Lyons as chief development officer. Having served as Erdene’s vice president Business Development since 2015, Ankhbayar is a seasoned executive with North American and Mongolian experience. Since returning to Mongolia from Canada in 2010, he has held the roles of CEO of Monrud LLC, a full service logistics and mine support management firm, and CEO of Mongolian Investment Banking Group, a domestic investment dealer. Lyons, prior to his appointment as chief development officer, has been employed as Erdene’s vice president projects since 2021, with responsibility for the overall delivery of the company’s projects within scope, budget, and schedule. He has lived and worked in Mongolia and the region, including a previous posting with Erdene, since 2001. Additionaly, the company also announced that its shareholders voted in favour of all items of business brought before them at the company's Annual and Special Meeting of Shareholders held on June 22, 2023 in Halifax, Nova Scotia.
Q BioMed Inc has provided an update to its shareholders, stating that it was unable to file complete audited financials for 2022 due to capital constraints and audit costs. As a result, the company's OTC listing compliance was downgraded, and it is now exploring options such as restructuring, funding, relisting, or potential mergers and acquisitions to address its financial challenges and unlock shareholder value. Q BioMed is actively engaged with consultants and bankers in pursuit of a solution.
Givex Corp said it has applied to the Toronto Stock Exchange (TSX) to extend the term of an aggregate of 11,000,000 common share purchase warrants which were issued on November 25, 2021 in connection with a private placement concurrent with the company's listing on the TSX. The current expiry date of the warrants is November 25, 2023 and the new expiry date will be November 25, 2024. All other terms of the warrants will remain unchanged, including the exercise price of $1.25. A total of 183,330 of the warrants are held directly or indirectly by insiders of the company.